LMIM
BSX icon

Lockheed Martin Investment Management’s Boston Scientific BSX Stock Holding History

Lockheed Martin Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.39M Buy
85,920
+31,370
+58% +$2.51M 0.2% 76
2025
Q4 		$5.2M Buy
54,550
+5,840
+12% +$573K 0.17% 73
2025
Q3 		$4.76M Sell
48,710
-1,800
-4% -$186K 0.18% 79
2025
Q2 		$5.43M Sell
50,510
-3,430
-6% -$347K 0.2% 77
2025
Q1 		$5.44M Sell
53,940
-1,280
-2% -$129K 0.22% 74
2024
Q4 		$4.93M Sell
55,220
-740
-1% -$65.1K 0.2% 70
2024
Q3 		$4.69M Sell
55,960
-66,520
-54% -$5.24M 0.22% 69
2024
Q2 		$9.43M Sell
122,480
-4,410
-3% -$323K 0.55% 44
2024
Q1 		$7.18M Sell
126,890
-108,542
-46% -$6.98M 0.52% 43
2023
Q4 		$11.7M Sell
235,432
-35,900
-13% -$1.92M 0.84% 33
2023
Q3 		$12.8M Sell
271,332
-45,630
-14% -$2.39M 0.98% 26
2023
Q2 		$17.1M Sell
316,962
-3,000
-0.9% -$157K 0.98% 27
2023
Q1 		$16M Buy
319,962
+56,190
+21% +$2.65M 0.91% 24
2022
Q4 		$12.2M Buy
263,772
+55,670
+27% +$2.41M 0.81% 38
2022
Q3 		$8.06M Hold
208,102
– – 0.65% 49
2022
Q2 		$7.75M Sell
208,102
-13,780
-6% -$561K 0.53% 49
2022
Q1 		$9.83M Buy
221,882
+19,610
+10% +$850K 0.54% 51
2021
Q4 		$8.59M Hold
202,272
– – 0.46% 53
2021
Q3 		$8.78M Sell
202,272
-98,480
-33% -$4.36M 0.48% 42
2021
Q2 		$12.9M Sell
300,752
-88,030
-23% -$3.7M 0.67% 36
2021
Q1 		$15M Buy
388,782
+121,920
+46% +$4.61M 0.77% 37
2020
Q4 		$9.59M Sell
266,862
-143,000
-35% -$5.15M 0.5% 50
2020
Q3 		$15.7M Sell
409,862
-45,190
-10% -$1.74M 0.97% 20
2020
Q2 		$16M Hold
455,052
– – 1.06% 18
2020
Q1 		$14.8M Buy
455,052
+64,500
+17% +$2.52M 1.01% 18
2019
Q4 		$17.7M Buy
390,552
+50,312
+15% +$2.11M 0.93% 22
2019
Q3 		$13.8M Sell
340,240
-9,560
-3% -$405K 0.88% 18
2019
Q2 		$15M Buy
349,800
+159,100
+83% +$6.12M 0.68% 35
2019
Q1 		$7.32M Buy
190,700
+128,900
+209% +$4.92M 0.33% 45
2018
Q4 		$2.18M Buy
+61,800
New +$2.24M 0.1% 50
2017
Q3 		– Sell
-137,000
Closed -$3.8M – 133
2017
Q2 		$3.8M Buy
+137,000
New +$3.64M 0.21% 62

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lockheed Martin Investment Management's BSX Position: Q1 2026 in Review

Lockheed Martin Investment Management increased its Boston Scientific (BSX) stake by 58% in Q1 2026, buying an estimated $2.51M and bringing the position to 85,920 shares worth $5.39M. The position accounts for 0.2% of the portfolio, ranked #76.

Lockheed Martin Investment Management first reported a position in BSX in Q2 2017 and has held it in 31 quarters since. The position peaked at $17.7M in Q4 2019. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Lockheed Martin Investment Management held 85,920 shares of Boston Scientific worth $5.39M as of Q1 2026.
  • Lockheed Martin Investment Management bought 31,370 Boston Scientific shares in Q1 2026, an estimated $2.51M.
  • Boston Scientific made up 0.2% of Lockheed Martin Investment Management's portfolio in Q1 2026, its #76 holding.
  • Lockheed Martin Investment Management first reported a position in Boston Scientific in Q2 2017 and has held it in 31 quarters since.
  • Lockheed Martin Investment Management's Boston Scientific position peaked at $17.7M in Q4 2019.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Lockheed Martin Investment Management's 13F filing for Q1 2026, filed 7 May 2026.